DECIPHERA PHARMACEUTICALS IN - COM (DCPH)

Historical Holders from Q3 2017 to Q3 2024

Type / Class
Equity / COM
Symbol
DCPH
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2024 Q3 0 $0 -$759,000 0
2024 Q2 50,000 $759,000 -$941,753,291 $15.18 1
2024 Q1 59,993,887 $943,651,739 +$32,281,648 $15.73 176
2023 Q4 57,960,273 $934,914,487 +$29,373,278 $16.13 163
2023 Q3 56,573,682 $719,615,935 +$2,422,578 $12.72 155
2023 Q2 56,212,844 $792,074,465 -$25,997,353 $14.08 143
2023 Q1 58,028,090 $896,532,937 +$84,832,453 $15.45 146
2022 Q4 52,271,711 $856,719,315 +$346,011 $16.39 142
2022 Q3 49,124,220 $908,712,891 +$8,384,641 $18.50 151
2022 Q2 47,907,362 $629,994,430 +$67,750,151 $13.15 120
2022 Q1 43,490,955 $403,158,980 -$23,495,625 $9.27 115
2021 Q4 45,818,944 $447,595,905 -$376,588,200 $9.77 132
2021 Q3 42,726,749 $1,451,713,815 -$28,219,696 $33.98 159
2021 Q2 42,124,071 $1,542,061,517 -$3,925,227 $36.61 142
2021 Q1 43,030,143 $1,929,268,782 -$28,535,062 $44.84 161
2020 Q4 43,187,003 $2,464,411,609 +$27,975,744 $57.07 177
2020 Q3 42,507,347 $2,180,668,586 -$15,408,883 $51.30 160
2020 Q2 42,636,598 $2,510,222,169 +$114,333,128 $59.72 164
2020 Q1 40,714,068 $1,676,215,251 +$188,805,708 $41.17 145
2019 Q4 35,707,187 $2,222,345,778 +$26,407,600 $62.24 151
2019 Q3 35,426,818 $1,202,354,184 +$425,965,449 $33.94 120
2019 Q2 23,143,701 $521,923,638 +$15,274,819 $22.55 85
2019 Q1 22,485,191 $521,884,094 +$15,004,458 $23.21 80
2018 Q4 21,905,347 $459,791,066 -$21,048,445 $20.99 77
2018 Q3 21,180,198 $820,096,834 +$17,273,238 $38.72 87
2018 Q2 20,801,980 $818,555,896 +$205,044,169 $39.35 89
2018 Q1 15,615,503 $312,935,879 -$5,208,180 $20.04 54
2017 Q4 15,708,045 $355,184,292 +$31,466,123 $22.67 59
2017 Q3 14,570,860 $274,933,000 +$274,743,003 $18.99 50